Keyphrases
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
CXCR4 Antagonist
100%
Metastatic Lung Cancer
100%
Stromal Cells
50%
Lung Cancer Cells
50%
Non-small Cell Lung Cancer (NSCLC)
33%
Chemokine Receptor
33%
Non-small Cell Lung Cancer Cells
33%
Clinical Development
16%
Metastatic Disease
16%
Poor Prognosis
16%
Chemotherapy
16%
Radiotherapy
16%
Tumor Cells
16%
Tumor Metastasis
16%
Transmembrane
16%
Lung Cancer
16%
Drug Resistance
16%
Cancer Cell Migration
16%
Therapeutic Approaches
16%
Lung Cancer Patients
16%
Adhesion Molecules
16%
Death Rate
16%
New Treatment Options
16%
G Protein-coupled
16%
Cytotoxic Drugs
16%
Microenvironment
16%
Chemokine Ligand 12 (CXCL12)
16%
Tumor Microenvironment
16%
Leukocyte Trafficking
16%
Stromal Cell-derived factor-1 (SDF-1)
16%
Tumor Cell Migration
16%
Cancer Cell Adhesion
16%
Preclinical Development
16%
Tumor Cell Adhesion
16%
AMD3100
16%
Growth Resistance
16%
Plerixafor
16%
CXCR4/CXCL12 Axis
16%
T140
16%
Receptor Molecules
16%
Resistance Signal
16%
TN14003
16%
CD184
16%
Tumor-stroma Crosstalk
16%
Medicine and Dentistry
Lung Cancer
100%
Chemokine Receptor CXCR4 Antagonist
100%
Tumor Cell
50%
Cancer Cell
50%
Stromal Cell
50%
Metastatic Carcinoma
33%
Cell Adhesion
33%
Cell Migration
33%
Non Small Cell Lung Cancer
33%
Chemokine Receptor
33%
Small Cell Lung Cancer
33%
Stromal Cell Derived Factor 1
33%
Plerixafor
33%
Neoplasm
16%
Mortality Rate
16%
Radiation Therapy
16%
Leukocyte
16%
Cytotoxic Agent
16%
Guanine Nucleotide Binding Protein
16%
Drug Resistance
16%
Stroma
16%
Cell Adhesion Proteins
16%
Tumor Microenvironment
16%
T 140
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Chemokine Receptor CXCR4 Antagonist
100%
Neoplasm
66%
Non Small Cell Lung Cancer
33%
Chemokine Receptor
33%
Small Cell Lung Cancer
33%
Plerixafor
33%
Stromal Cell Derived Factor 1
33%
Metastasis
16%
Mortality Rate
16%
Chemotherapy
16%
Drug Resistance
16%
Guanine Nucleotide Binding Protein
16%
Cytotoxic Agent
16%
Cell Adhesion Proteins
16%
Tumor Microenvironment
16%
T 140
16%